Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The impact of environmental infections (parasites) on MS activity.
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
Celiac disease and multiple sclerosis in the northwest of Iran.
Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test.
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
Video game training enhances cognitive control in older adults.
Characterization of human platelet binding of recombinant T cell receptor ligand.
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
Connective Tissue and its Growth Factor, CTGF, Distinguish the Morphometric and Molecular Remodeling of the Bladder in a Model of Neurogenic Bladder.
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.
Transverse myelitis associated with heroin and cannabis abuse: a new issue from the past.
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Psoriasis during natalizumab treatment for multiple sclerosis.
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
Endogenous retroviruses and multiple sclerosis--new pieces to the puzzle.
Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy.
Mutations affecting segment number and polarity in Drosophila.

Pages